{"filing":{"accession_number":"0001649094-26-000021","cik":"0001649094","ticker":"PCVX","company_name":"Vaxcyte, Inc.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"pcvx-20260615.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909426000021/pcvx-20260615.htm"},"events":[{"id":11311,"run_id":9929,"accession_number":"0001649094-26-000021","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Vaxcyte's June 15, 2026 Annual Meeting of Stockholders, covering three matters: election of three Class III directors (Olivier Brandicourt, Halley Gilbert, and Grant Pickering), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies (for, against, withheld, abstain, broker non-votes) for each matter, which is the standard format for Item 5.07 disclosures.","company_name":"Vaxcyte, Inc.","ticker":"PCVX","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7869,"accession_number":"0001649094-26-000021","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Vaxcyte's June 15, 2026 Annual Meeting of Stockholders, covering three matters: election of three Class III directors (Olivier Brandicourt, Halley Gilbert, and Grant Pickering), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies (for, against, withheld, abstain, broker non-votes) for each matter, which is the standard format for Item 5.07 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:13:08.071913+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7869,"accession_number":"0001649094-26-000021","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Vaxcyte's June 15, 2026 Annual Meeting of Stockholders, covering three matters: election of three Class III directors (Olivier Brandicourt, Halley Gilbert, and Grant Pickering), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies (for, against, withheld, abstain, broker non-votes) for each matter, which is the standard format for Item 5.07 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:13:08.071913+00:00","company_name":"Vaxcyte, Inc.","ticker":"PCVX","filing_date":"2026-06-16"}]}